Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: ...

Weight gain is common in women during perimenopause and after menopause, but the physical changes underlying it start much ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

Reuters spoke to three-dozen people inside the industry including retailers, drugmakers, telehealth providers and investors to show how the weight-loss sector is shifting to better meet consumers ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

NEW YORK >> Packaged food makers and fast-food restaurants may ‌be forced to overhaul more of their products next year as ...

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.